Article
The Impact of Expanded Access to Germline High Penetrance Genetic Testing for Women With a New Diagnosis of Invasive Breast Cancer or High-Grade DCIS.
Clinical breast cancer - 1 Sept 2026
Hudson-Phillips Sarah P, Nanda Akriti, Attia Mohamed, Al Yaqout Wadha, Marshall Evelyn, Rusby Jennifer E, Krupa Katherine, Barry Peter A, Tasoulis Marios Konstantinos, Gui Gerald, Merh Radhika, Torr Bethany, Kemp Zoe, George Angela, Turnbull Clare, O'Connell Rachel L
Abstract excerpt
BACKGROUND: Approximately 3% of patients with breast cancer have an inherited pathogenic variant in high-penetrance genes such as BRCA1, BRCA2 or PALB2. Knowledge of genetic testing result may impact surgery undertaken at the time of index breast cancer treatment. The aim of this study was to evaluate the impact of a positive high penetrance genetic test (HPGT) on surgical decision-making. METHODS: Females >18...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Breast Neoplasms
- Genetic Testing
- Middle Aged
